Discovery of a Highly Potent, Orally Active Mitosis/Angiogenesis Inhibitor R1530 for the Treatment of Solid Tumors

被引：20

作者：

Liu, Jin-Jun ^{[1
]}

Higgins, Brian ^{[2
]}

Ju, Grace ^{[2
]}

Kolinsky, Kenneth ^{[2
]}

Luk, Kin-Chun ^{[1
]}

Packman, Kathryn ^{[2
]}

Pizzolato, Giacomo ^{[1
]}

Ren, Yi ^{[3
]}

Thakkar, Kshitij ^{[1
]}

Tovar, Christian ^{[2
]}

Zhang, Zhuming ^{[1
]}

Woykulich, Peter M. ^{[1
]}

机构：

[1] Hoffmann La Roche Inc, Discovery Chem, Nutley, NJ 07110 USA

[2] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ 07110 USA

[3] Hoffmann La Roche Inc, Chem Synth, Nutley, NJ 07110 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 02期

关键词：

pyrazolobenzodiazepines; mitosis/angiogenesis inhibitor; antitumor effect; VGFr-2; FGFr and PDGFr-beta; ORTHO-SUBSTITUTION-REACTION; ORGANIC-SYNTHESIS; ANGIOGENESIS; CANCER; AMINOHALOBORANE; COMBINATION; THERAPY;

D O I：

10.1021/ml300351e

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of 7,8-disubstituted pyrazolobenzodiazepines based on the lead compound 1 have been synthesized and evaluated for their effects on mitosis and angiogenesis. Described herein is the design, synthesis, SAR, and antitumor activity of these compounds leading to the identification of R1530, which was selected for clinical evaluation.

引用

页码：259 / 263

页数：5

共 50 条

[1] Preclinical testing of tumor and angiogenesis inhibitor R1530 in a rat prostatic adenocarcinoma model
Herting, Frank
Kolinsky, Kenneth
Hort, Stefan
Muth, Gunther
Abraham, Esther
Smith, Melissa
Geng, Wanping
Zhang, Yu-E
Tovar, Christain
Packman, Kathryn
Higgins, Brian
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3414S - 3414S
[2] Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
Dorsey, Bruce D.
Iqbal, Mohamed
Chatterjee, Sankar
Menta, Ernesto
Bernardini, Raffaella
Bernareggi, Alberto
Cassara, Paolo G.
D'Arasmo, Germano
Ferretti, Edmondo
De Munari, Sergio
Oliva, Ambrogio
Pezzoni, Gabriella
Allievi, Cecilia
Strepponi, Ivan
Ruggeri, Bruce
Ator, Mark A.
Williams, Michael
MallamoT, John P.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 1068 - 1072
[3] Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor
He, Pengxing
Niu, Shenghui
Wang, Shuai
Shi, Xiaojing
Feng, Siqi
Du, Linna
Zhang, Xuyang
Ma, Zhilu
Yu, Bin
Liu, Hongmin
ACTA PHARMACEUTICA SINICA B, 2019, 9 (06) : 1193 - 1203
[4] Discovery of WS-157 as a highly potent,selective and orally active EGFR inhibitor
Pengxing He
Shenghui Niu
Shuai Wang
Xiaojing Shi
Siqi Feng
Linna Du
Xuyang Zhang
Zhilu Ma
Bin Yu
Hongmin Liu
Acta Pharmaceutica Sinica B, 2019, 9 (06) : 1193 - 1203
[5] Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor
Iijima, Daisuke
Sugama, Hiroshi
Takahashi, Yoichi
Hirai, Miki
Togashi, Yuko
Xie, Jianshu
Shen, Jingkang
Ke, Ying
Akatsuka, Hidenori
Kawaguchi, Takayuki
Takedomi, Kei
Kashima, Akiko
Nishio, Masashi
Inui, Yosuke
Yoneda, Hikaru
Xia, Guangxin
Iijima, Toru
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 10882 - 10897
[6] Discovery and development of anacetrapib, a potent and orally active CETP inhibitor
Ali, Amjad
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[7] Discovery and preclinical characterization of BMN 673, a highly potent and orally active PARP inhibitor as an anticancer agent
Wang, Bing
Chu, Daniel
Shen, Yuqiao
Feng, Ying
Myers, Peter
Post, Leonard
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[8] Discovery of a Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitor for the Potential Treatment of Schizophrenia
Manuel Bartolome-Nebreda, Jose
Delgado, Francisca
Luz Martin-Martin, Maria
Martinez-Viturro, Carlos M.
Pastor, Joaquin
Min Tong, Han
Iturrino, Laura
Macdonald, Gregor J.
Sanderson, Wendy
Megens, Anton
Langlois, Xavier
Somers, Marijke
Vanhoof, Greet
Conde-Ceide, Susana
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 4196 - 4212
[9] Discovery of SC110237, a highly potent, selective and orally active FLT3 inhibitor for the treatment of acute myeloid leukemia
Kong, Norman
Gao, Daxin
Yang, Heping
Yu, Yajun
CANCER RESEARCH, 2015, 75
[10] Discovery of a potent and highly selective, orally efficacious IKK2 inhibitor for the treatment of rheumatoid arthritis
Liddle, John
Williamson, Rick A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238

← 1 2 3 4 5 →